Evidence method
Level · gp.fundamentals.debt_to_revenue
39.26% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
HBIO · Dec 31, 2024
HARVARD BIOSCIENCE INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001171843-25-001472General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
2.81% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
1.53% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-16.14% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
24.69% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
58.18% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-6.60% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
11.05% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
4.61% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History16 statesHistory building
Sep 30, 20220/8 normalizedLevel 3Dec 31, 20220/8 normalizedLevel 3Mar 31, 20230/8 normalizedLevel 3Jun 30, 20230/8 normalizedLevel 3Sep 30, 20230/9 normalizedLevel 3Dec 31, 20230/9 normalizedLevel 3Mar 31, 20240/9 normalizedLevel 3Jun 30, 20240/9 normalizedLevel 3Sep 30, 20248/9 normalizedLevel 3Dec 31, 20248/9 normalizedLevel 3Mar 31, 20258/9 normalizedLevel 3Jun 30, 20258/9 normalizedLevel 3Sep 30, 20259/9 normalizedLevel 3Dec 31, 20259/9 normalizedLevel 3Mar 31, 20269/9 normalizedLevel 3Jun 30, 20269/9 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 172.32%
- Current
- 39.26%
- Delta
- -133.07%
- Previous
- 4.01%
- Current
- 2.81%
- Delta
- -1.20%
- Previous
- -3.83%
- Current
- 1.53%
- Delta
- 5.36%
- Previous
- -13.38%
- Current
- -16.14%
- Delta
- -2.76%
- Previous
- 118.30%
- Current
- 24.69%
- Delta
- -93.61%
- Previous
- 58.10%
- Current
- 58.18%
- Delta
- 0.07%
- Previous
- -8.53%
- Current
- -6.60%
- Delta
- 1.93%
- Previous
- 11.68%
- Current
- 11.05%
- Delta
- -0.63%
- Previous
- 4.79%
- Current
- 4.61%
- Delta
- -0.18%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · HBIO Fundamental State →Has State · HARVARD BIOSCIENCE INC →Transitioned To · HBIO BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · HBIO CAPEX_INTENSITY_DECREASED →Transitioned To · HBIO CASH_GENERATION_INCREASED →Transitioned To · HBIO GROWTH_DECREASED →Transitioned To · HBIO INVENTORY_PRESSURE_DECREASED →Transitioned To · HBIO MARGIN_INCREASED →Transitioned To · HBIO PROFITABILITY_INCREASED →Transitioned To · HBIO R_AND_D_INTENSITY_DECREASED →Transitioned To · HBIO SBC_INTENSITY_DECREASED →Transitioned To · HBIO Fundamental State →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.